Chlamydia, Gonorrhea
CPT Code(s):
87491, 87591
Turnaround Time:
24 hours
Specimen Requirements
Preferred Specimen:
Urine or Vaginal, Anorectal, Oropharyngeal Swab
Minimum Volume:
1.0 mL (or 1 swab)
Transport Container:
PCR Media Uni Swab Sample Kit
Transport Temperature:
Room Temperature
Collection Instructions:
First void urine specimens kept at 2�30 �C must be transferred from the collection cup to the PCR Tube within 4 hours of collection, or within 24 hours when stored at 2�8 �C.
Rejection Criteria:
Specimen received in preservative other than PCR Media Uni Swab kit
Stability Criteria
Room Temperature:
12 months
Refrigerated:
12 months
Frozen:
Unacceptable
Clinical Significance
The Chlamydia, Gonorrhea (CT/NG) test holds specific clinical significance and diagnostic use in the field of sexually transmitted infection (STI) testing and prevention. This test is designed to detect the presence of two common bacterial pathogens, Chlamydia trachomatis and Neisseria gonorrhoeae, which are responsible for the most prevalent bacterial STIs worldwide.
The clinical significance and diagnostic use of the Chlamydia, Gonorrhea test include:
1. Diagnosis of Chlamydia and Gonorrhea Infections: The primary purpose of the Chlamydia, Gonorrhea test is to diagnose Chlamydia trachomatis and Neisseria gonorrhoeae infections in both men and women. These infections can cause a range of symptoms, including genital discharge, pain during urination, pelvic pain, and in some cases, complications such as pelvic inflammatory disease (PID). However, many infected individuals may remain asymptomatic. The test is used to identify the presence of these bacteria, facilitating early diagnosis and appropriate treatment.
2. Screening for Asymptomatic Infections: Chlamydia and gonorrhea infections are often asymptomatic, especially in women. As a result, screening programs are crucial for identifying and treating asymptomatic individuals to prevent the spread of infection and potential complications. The Chlamydia, Gonorrhea test is used for routine screening in sexually active individuals, particularly those at higher risk or with a history of STIs.
3. Partner Management and Contact Tracing: The Chlamydia, Gonorrhea test is valuable in partner management and contact tracing. When an individual tests positive for Chlamydia or gonorrhea, their sexual partners need to be identified and informed so they can undergo testing and receive appropriate treatment. This helps prevent reinfection and further transmission of the infections.
4. Prevention of Complications: Timely detection and treatment of Chlamydia and gonorrhea infections are crucial to prevent complications. If left untreated, these infections can lead to serious reproductive health problems in women, such as pelvic inflammatory disease (PID), infertility, ectopic pregnancy, and chronic pelvic pain. In men, untreated gonorrhea can lead to epididymitis and, in rare cases, sterility. The Chlamydia, Gonorrhea test aids in early detection, allowing for prompt treatment and prevention of these complications.
5. Monitoring Treatment Response: The Chlamydia, Gonorrhea test is used to monitor the response to treatment. Following treatment, a repeat test is recommended to ensure the infections have been successfully cleared. Monitoring treatment response is important to confirm eradication of the bacteria and prevent reinfection or persistent infection.
In summary, the Chlamydia, Gonorrhea test has specific clinical significance in the diagnosis of Chlamydia and gonorrhea infections, screening for asymptomatic infections, partner management and contact tracing, prevention of complications, and monitoring treatment response. By detecting the presence of Chlamydia trachomatis and Neisseria gonorrhoeae, this test provides valuable information for clinical decision-making, enabling healthcare providers to diagnose and manage these STIs, initiate timely treatment, prevent complications, and promote sexual health and well-being.
CPT Code(s):
87491, 87591
Turnaround Time:
24 hours
Specimen Requirements
Preferred Specimen:
Urine or Vaginal, Anorectal, Oropharyngeal Swab
Minimum Volume:
1.0 mL (or 1 swab)
Transport Container:
PCR Media Uni Swab Sample Kit
Transport Temperature:
Room Temperature
Collection Instructions:
First void urine specimens kept at 2�30 �C must be transferred from the collection cup to the PCR Tube within 4 hours of collection, or within 24 hours when stored at 2�8 �C.
Rejection Criteria:
Specimen received in preservative other than PCR Media Uni Swab kit
Stability Criteria
Room Temperature:
12 months
Refrigerated:
12 months
Frozen:
Unacceptable
Clinical Significance
The Chlamydia, Gonorrhea (CT/NG) test holds specific clinical significance and diagnostic use in the field of sexually transmitted infection (STI) testing and prevention. This test is designed to detect the presence of two common bacterial pathogens, Chlamydia trachomatis and Neisseria gonorrhoeae, which are responsible for the most prevalent bacterial STIs worldwide.
The clinical significance and diagnostic use of the Chlamydia, Gonorrhea test include:
1. Diagnosis of Chlamydia and Gonorrhea Infections: The primary purpose of the Chlamydia, Gonorrhea test is to diagnose Chlamydia trachomatis and Neisseria gonorrhoeae infections in both men and women. These infections can cause a range of symptoms, including genital discharge, pain during urination, pelvic pain, and in some cases, complications such as pelvic inflammatory disease (PID). However, many infected individuals may remain asymptomatic. The test is used to identify the presence of these bacteria, facilitating early diagnosis and appropriate treatment.
2. Screening for Asymptomatic Infections: Chlamydia and gonorrhea infections are often asymptomatic, especially in women. As a result, screening programs are crucial for identifying and treating asymptomatic individuals to prevent the spread of infection and potential complications. The Chlamydia, Gonorrhea test is used for routine screening in sexually active individuals, particularly those at higher risk or with a history of STIs.
3. Partner Management and Contact Tracing: The Chlamydia, Gonorrhea test is valuable in partner management and contact tracing. When an individual tests positive for Chlamydia or gonorrhea, their sexual partners need to be identified and informed so they can undergo testing and receive appropriate treatment. This helps prevent reinfection and further transmission of the infections.
4. Prevention of Complications: Timely detection and treatment of Chlamydia and gonorrhea infections are crucial to prevent complications. If left untreated, these infections can lead to serious reproductive health problems in women, such as pelvic inflammatory disease (PID), infertility, ectopic pregnancy, and chronic pelvic pain. In men, untreated gonorrhea can lead to epididymitis and, in rare cases, sterility. The Chlamydia, Gonorrhea test aids in early detection, allowing for prompt treatment and prevention of these complications.
5. Monitoring Treatment Response: The Chlamydia, Gonorrhea test is used to monitor the response to treatment. Following treatment, a repeat test is recommended to ensure the infections have been successfully cleared. Monitoring treatment response is important to confirm eradication of the bacteria and prevent reinfection or persistent infection.
In summary, the Chlamydia, Gonorrhea test has specific clinical significance in the diagnosis of Chlamydia and gonorrhea infections, screening for asymptomatic infections, partner management and contact tracing, prevention of complications, and monitoring treatment response. By detecting the presence of Chlamydia trachomatis and Neisseria gonorrhoeae, this test provides valuable information for clinical decision-making, enabling healthcare providers to diagnose and manage these STIs, initiate timely treatment, prevent complications, and promote sexual health and well-being.
CPT Code(s):
87491, 87591
Turnaround Time:
24 hours
Specimen Requirements
Preferred Specimen:
Urine or Vaginal, Anorectal, Oropharyngeal Swab
Minimum Volume:
1.0 mL (or 1 swab)
Transport Container:
PCR Media Uni Swab Sample Kit
Transport Temperature:
Room Temperature
Collection Instructions:
First void urine specimens kept at 2�30 �C must be transferred from the collection cup to the PCR Tube within 4 hours of collection, or within 24 hours when stored at 2�8 �C.
Rejection Criteria:
Specimen received in preservative other than PCR Media Uni Swab kit
Stability Criteria
Room Temperature:
12 months
Refrigerated:
12 months
Frozen:
Unacceptable
Clinical Significance
The Chlamydia, Gonorrhea (CT/NG) test holds specific clinical significance and diagnostic use in the field of sexually transmitted infection (STI) testing and prevention. This test is designed to detect the presence of two common bacterial pathogens, Chlamydia trachomatis and Neisseria gonorrhoeae, which are responsible for the most prevalent bacterial STIs worldwide.
The clinical significance and diagnostic use of the Chlamydia, Gonorrhea test include:
1. Diagnosis of Chlamydia and Gonorrhea Infections: The primary purpose of the Chlamydia, Gonorrhea test is to diagnose Chlamydia trachomatis and Neisseria gonorrhoeae infections in both men and women. These infections can cause a range of symptoms, including genital discharge, pain during urination, pelvic pain, and in some cases, complications such as pelvic inflammatory disease (PID). However, many infected individuals may remain asymptomatic. The test is used to identify the presence of these bacteria, facilitating early diagnosis and appropriate treatment.
2. Screening for Asymptomatic Infections: Chlamydia and gonorrhea infections are often asymptomatic, especially in women. As a result, screening programs are crucial for identifying and treating asymptomatic individuals to prevent the spread of infection and potential complications. The Chlamydia, Gonorrhea test is used for routine screening in sexually active individuals, particularly those at higher risk or with a history of STIs.
3. Partner Management and Contact Tracing: The Chlamydia, Gonorrhea test is valuable in partner management and contact tracing. When an individual tests positive for Chlamydia or gonorrhea, their sexual partners need to be identified and informed so they can undergo testing and receive appropriate treatment. This helps prevent reinfection and further transmission of the infections.
4. Prevention of Complications: Timely detection and treatment of Chlamydia and gonorrhea infections are crucial to prevent complications. If left untreated, these infections can lead to serious reproductive health problems in women, such as pelvic inflammatory disease (PID), infertility, ectopic pregnancy, and chronic pelvic pain. In men, untreated gonorrhea can lead to epididymitis and, in rare cases, sterility. The Chlamydia, Gonorrhea test aids in early detection, allowing for prompt treatment and prevention of these complications.
5. Monitoring Treatment Response: The Chlamydia, Gonorrhea test is used to monitor the response to treatment. Following treatment, a repeat test is recommended to ensure the infections have been successfully cleared. Monitoring treatment response is important to confirm eradication of the bacteria and prevent reinfection or persistent infection.
In summary, the Chlamydia, Gonorrhea test has specific clinical significance in the diagnosis of Chlamydia and gonorrhea infections, screening for asymptomatic infections, partner management and contact tracing, prevention of complications, and monitoring treatment response. By detecting the presence of Chlamydia trachomatis and Neisseria gonorrhoeae, this test provides valuable information for clinical decision-making, enabling healthcare providers to diagnose and manage these STIs, initiate timely treatment, prevent complications, and promote sexual health and well-being.